miDiagnostics
ActiveSummary
The computed 12-month bankruptcy probability of miDiagnostics is 2.5% (moderate). The 2025 annual accounts show negative equity (-€10.6m) and a net result of -€12.6m. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 5% of 237 sector peers (NACE 72, financial year 2025). The company has been active since 2015 and the Belgian Official Gazette contains no insolvency or warning signals.
Articles of association
- Transfer restrictionWhether shareholders may sell their shares freely or need approval first.
- “Minstens hoogste van (i)aangeboden prijs per Kapitaalsaandeel van relevante klasse of tegenwaarde zoals in Kennisgeving of (ii)gewogen…” (deed in Dutch)“Voorkooprecht niet van toepassing op Overdracht ingevolge toepassing van en uitgevoerd overeenkomstig volgrecht/gezamenlijke Exit en vrije…” (deed in Dutch)4 more provisions on this in the deed
- Other provisionsOther rules from the articles that fall under none of the themes above.
- 3 more provisions in the deed, see the deed of 02-01-2025
Read from the deeds: 9 provisions, deed of 02-01-2025